L-Glutathione Capsules (ProThera) – Mis-packaging Issue (2018)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Klaire Labs Reduced L-Glutathione 150 mg capsules, single capsule dose 100 vegetarian capsules SKU V799-10 UPC Code: 7 09616 79910 9
Brand
ProThera, Inc. dba SFI USA
Lot Codes / Batch Numbers
FG Lot: 2018210303 Expiration: 05/2020
Products Sold
FG Lot: 2018210303 Expiration: 05/2020
ProThera, Inc. dba SFI USA is recalling Klaire Labs Reduced L-Glutathione 150 mg capsules, single capsule dose 100 vegetarian capsules S due to Mis-packaging; product is labeled as Reduce L-Glutathione but actually contains Lithium Orotate.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Mis-packaging; product is labeled as Reduce L-Glutathione but actually contains Lithium Orotate.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
AL, AZ, CA, KS, LA, MI, MO, NH, NJ, NY, OR, PA, TX, WA
Page updated: Jan 6, 2026